De-regulated STAT5A/miR-202-5p/USP15/Caspase-6 regulatory axis suppresses CML cell apoptosis and contributes to Imatinib resistance. This evidence concerns the gene USP15 and chronic myelogenous leukemia, BCR-ABL1 positive.